1 SEC 13D/G filing tracked · Last updated Sep 25, 2026
$KOD KOD - Kodiak Sciences to Present Topline Results on September 28, 2026 from DAYBREAK Pivotal Phase 3 Study of Zenkuda and KSI-501 in Patients wit…
